Schizophrenia
Research Study
This research study is testing Cobenfy, the first medication in a new class of antipsychotics approved by the FDA. Unlike existing treatments, Cobenfy works through a different mechanism of action, which may offer new benefits for people experiencing schizophrenia. The study focuses on adults who are in their first episode or early phase of schizophrenia. By participating, you can help researchers understand whether Cobenfy improves positive symptoms more effectively than other antipsychotics.
Fast Facts
Adults diagnosed with schizophrenia
Have been on a stable dose of antipsychotic medication
Compensation
provided
Conducted in
Eugene, Oregon
Additional Information
Researchers want to learn how Cobenfy, the first drug of its kind, affects people with early-phase schizophrenia and whether it is more effective than current antipsychotics.
You may be eligible for this study if you meet the following criteria.
Inclusion Criteria:
- Ages 18-40
- Diagnosed with schizophrenia
- Have been on a stable dose of antipsychotic medication
- Willing to change medication as part of the study
- Live in Oregon
Exclusion Criteria:
- Not currently taking an antipsychotic medication or unwilling to switch
- Recent hospitalization
Overall Duration
This study will last about 8 months in total. This includes a 3-week screening period, about 24 weeks of treatment, and a follow-up visit one month after treatment ends.
In-Lab Activities
All study visits take place in person. You will be asked to attend a total of 13 visits:
- 1 visit during the screening period
- 11 visits during the treatment period
- 1 follow-up visit after treatment
At these visits, you may:
- Meet with study staff and a physician
- Answer questions about your health and symptoms
- Receive the study medication (an FDA-approved treatment for schizophrenia)
- Have basic health checks, which may include blood work
Compensation will be provided for your participation. Snacks will be available at each visit, and transportation options such as Uber, taxi rides, and bus passes can be arranged.
There is no cost for you to participate in our research study.